Latest Funding News

Felix Gold Limited recently hosted senior U.S. federal officials at its Treasure Creek Antimony Project, highlighting its strategic role in addressing America’s critical mineral supply challenges amid China’s export ban.

Elixinol Wellness has raised $2.5 million through a well-supported placement and appointed industry veteran Gavin Evans as strategic advisor to drive its next phase of growth and operational reset.

Tasmea Limited has launched a $43 million institutional placement to strengthen its balance sheet for future acquisitions, following a robust FY25 with significant profit growth and margin expansion. The company’s FY26 guidance signals continued momentum driven by organic growth and strategic acquisitions.

Tasmea Limited has completed a fully underwritten A$43 million institutional placement, aiming to accelerate acquisitions, reduce debt, and enhance its chances of joining the ASX 300 Index.

Wagners Holding Company Limited has launched a A$30 million institutional placement to reduce debt and accelerate growth in its core Construction Materials and Composite Fibre Technologies businesses following a robust FY25 performance.

Wagners Holding Company Limited has secured $30 million through a strongly supported placement to fund growth in its construction materials and composite fibre technologies divisions.

Kuniko Limited has launched a partially underwritten rights issue to fund exploration at its Commonwealth Gold-Silver Project in New South Wales, aiming to capitalise on high-grade multi-metal potential in a Tier-1 jurisdiction.

Asra Minerals has raised $3.25 million to fast-track exploration at its Leonora Gold Projects in Western Australia, targeting high-grade zones and new prospects.

Austral Resources Australia Ltd is advancing its strategy to become a mid-tier copper producer by consolidating key assets in Queensland’s Mount Isa copper belt, supported by a $40 million capital raise.

Alterity Therapeutics has raised A$20 million through a strategic placement to advance its promising ATH434 treatment for Multiple System Atrophy, backed by encouraging Phase 2 trial results. The capital injection strengthens the company’s balance sheet as it prepares for regulatory discussions with the FDA.

Krakatoa Resources has deployed a second drill rig at its Zopkhito antimony-gold project in Georgia, accelerating efforts to convert historical resource estimates into a JORC-compliant Mineral Resource.

Theta Gold Mines appoints Hansjoerg Plaggemars as non-executive director and promotes Bill Richie Yang to executive director, bolstering financial and project development leadership as the TGME Gold Mine Project advances.